Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 3/20 | 0.86 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.86 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL10772395 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL155637 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL9119605 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL14881261 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL10771436 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL2945895 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL15228350 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL446467 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL10773987 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL9398134 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115521016-A | Treatment method for removing sulfate radicals and silicon in high-concentration salt wastewater | 阿奎特(广州)水处理有限公司 | 2022-12-27 | — | — | CN | claimed |
| WO-2014132226-A1 | STABLE DISPERSIBLE FORMULATION OF ARTEROLANE MALEATE AND PIPERAQUINE AND PROCESS OF PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2014-09-04 | — | — | WO | claimed |
| CN-103635436-A | Process for working up mine water | SIEMENS AG | 2014-03-12 | — | — | CN | claimed |
| CN-1321108-C | Process for synthesizing dicreatine malic acid | NANJIXING BIOLOG PRODUCT CO LT (CN) | 2007-06-13 | — | — | CN | claimed |
| CN-1683327-A | Process for synthesizing dicreatine malic acid | NANJIXING BIOLOG PRODUCT CO LT (CN) | 2005-10-19 | — | — | CN | claimed |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | ASCENDIS PHARMA A/S (DK) | 2026-04-07 | — | — | US | disclosed |
| US-20240174540-A1 | METHODS FOR RECOVERING FLY ASH USING A SELECTIVE FLOCCULANT | CHEMTREAT, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| CN-116997537-A | Low carbon construction binders and materials providing summer comfort | 马特尔阿普 | 2023-11-03 | — | — | CN | disclosed |
| CN-114437692-B | Alkaline detergent and preparation method thereof | 中国石油化工股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| CN-115521016-A | Treatment method for removing sulfate radicals and silicon in high-concentration salt wastewater | 阿奎特(广州)水处理有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-114437692-A | Alkaline scale dissolver and preparation method thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
| US-20210338834-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2021-11-04 | — | — | US | disclosed |
| US-20030055279-A1 | Process for the preparation of benzyl carboxylates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | US | disclosed |
| WO-1999020731-A1 | LAUNDRY BARS HAVING IMPROVED BLEACH STABILITY | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5173284-A | Forming aqueous solution by dissolution of calcium sulfate hemihydrate, separating solution from dissolved calcium sulfate, recrystallization, separation | LAFARGE COPPEE (FR) | 1992-12-22 | — | — | US | disclosed |
| EP-0046082-B1 | 8-AZA-16,16-DIFLUOROPROSTANOIDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-06-05 | — | — | EP | disclosed |
| US-RE31611-E | GROUP TWO CARBONATE AND H ALOGENATED ORGANIC LIQUID | ROCOL LIMITED (GB) | 1984-06-26 | — | — | US | disclosed |
| US-4320136-A | ANTIASTHMATIC, ANTIULCER PROSTAGLANDINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-03-16 | — | — | US | disclosed |
| EP-0046082-A2 | 8-Aza-16,16-difluoroprostanoids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-02-17 | — | — | EP | disclosed |
| US-3975399-A | PROSTAGLANDIN LIKE ACTIVITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338834-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | CD44, HPSE, MMP13 | CA5A 1545/4885CA5B 1702/4885TSHR 1264/4885 |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | CD44, H1-0, MMP1 | CA5A 675/4885CA5B 550/4885TSHR 493/4885 |
| US-20030055279-A1 | Process for the preparation of benzyl carboxylates | GABRG2, CA4, NBAS | CA5A 62/4885CA5B 45/4885TSHR 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.